SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
1.910
-0.040 (-2.05%)
At close: Jan 14, 2025, 4:00 PM
1.942
+0.032 (1.68%)
After-hours: Jan 14, 2025, 5:11 PM EST
SeaStar Medical Holding Employees
SeaStar Medical Holding had 12 employees as of December 31, 2023. The number of employees increased by 3 or 33.33% compared to the previous year.
Employees
12
Change (1Y)
3
Growth (1Y)
33.33%
Revenue / Employee
$5,667
Profits / Employee
-$2,489,000
Market Cap
8.52M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 12 | 3 | 33.33% |
| Dec 31, 2022 | 9 | 6 | 200.00% |
| Dec 31, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
ICU News
- 1 day ago - FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome - GlobeNewsWire
- 6 days ago - SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer - GlobeNewsWire
- 22 days ago - SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial - GlobeNewsWire
- 4 weeks ago - SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications - GlobeNewsWire
- 5 weeks ago - SeaStar Medical to Hold Business Update Conference Call on December 11, 2024 - GlobeNewsWire
- 7 weeks ago - SeaStar Medical to Present at Noble Capital Markets' NobleCon20 on December 4, 2024 - GlobeNewsWire
- 7 weeks ago - Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical's Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares - GlobeNewsWire
- 2 months ago - SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer - GlobeNewsWire